CompareMarketResearchRequest a sample
Home / Healthcare / Aniridia Implants

Healthcare · Market report

Aniridia Implants Market Size, Share and Forecast 2026-2036

The global aniridia implants market is worth USD 14 mn in 2026 and is forecast to reach USD 29 mn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Custom artificial iris is the largest by implant segment.

USD 14 mnMarket size 2026
USD 29 mnForecast 2036
7.5%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global aniridia implants market is worth USD 14 mn in 2026 and is forecast to reach USD 29 mn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Custom artificial iris is the largest by implant segment.

ScopeArtificial iris implants and iris reconstruction devices for aniridia, trauma and congenital iris loss, including custom-made iris and iris diaphragm rings.
IndustryHealthcare
Value 2025USD 13 mn
Value 2026USD 14 mn
Value 2036USD 29 mn
CAGR 2026-20367.5%
Volume 20263,224 units
Volume 20366,321 units
Average price 2026USD 4,355 per unit
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Aniridia Implants market size and forecast, 2026-2036

Exhibit 1The global aniridia implants market is forecast to grow from USD 14 mn in 2026 to USD 29 mn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 7.5%
Aniridia Implants market value, 2025 to 2036Market value by year. 2025: USD 13 mn; 2026: USD 14 mn; 2027: USD 15 mn; 2028: USD 16 mn; 2029: USD 17 mn; 2030: USD 19 mn; 2031: USD 20 mn; 2032: USD 22 mn; 2033: USD 23 mn; 2034: USD 25 mn; 2035: USD 27 mn; 2036: USD 29 mn. Compound annual growth rate 2026 to 2036: 7.5%.202514 mn202620 mn203129 mn20367.5% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 14 mn
2027USD 15 mn
2028USD 16 mn
2029USD 17 mn
2030USD 19 mn
2031USD 20 mn
2032USD 22 mn
2033USD 23 mn
2034USD 25 mn
2035USD 27 mn
2036USD 29 mn

Aniridia Implants market segmentation

By implant

Exhibit 2Custom artificial iris is the largest segment by implant, with 44.0% of 2026 revenueEstimated share of 2026 global revenue, by implant
Aniridia Implants market share by implant, 2026Share of 2026 revenue by implant. Custom artificial iris: 44.0%; Iris diaphragm and rings: 32.0%; Foldable prosthetic iris: 24.0%.Custom artificial iris44.0%Iris diaphragm and rings32.0%Foldable prosthetic iris24.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Custom artificial iris44.0%44.8%USD 6.2 mn7.7%
Iris diaphragm and rings32.0%28.4%USD 4.5 mn6.2%
Foldable prosthetic iris24.0%26.8%USD 3.4 mn8.7%

By cause

Exhibit 3Trauma adds the most revenue by cause, growing from USD 5.6 mn in 2026 to USD 11 mn by 2036Estimated revenue in USD by cause, 2026 and 2036 forecast
Aniridia Implants market by cause, 2026 and 2036Revenue by cause in 2026 and 2036. Trauma: USD 5.6 mn in 2026, USD 11 mn in 2036, change +95%; Ocular surgery related: USD 4.5 mn in 2026, USD 9.6 mn in 2036, change +114%; Congenital aniridia: USD 3.9 mn in 2026, USD 8.4 mn in 2036, change +114%.20262036 forecastChangeTrauma+95%5.6 mn11 mnOcular surgery related+114%4.5 mn9.6 mnCongenital aniridia+114%3.9 mn8.4 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Trauma40.0%37.8%USD 5.6 mn6.9%
Congenital aniridia28.0%29.0%USD 3.9 mn7.9%
Ocular surgery related32.0%33.2%USD 4.5 mn7.9%

By material

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Silicone56.0%53.0%USD 7.9 mn6.9%
Acrylic and polymethyl methacrylate24.0%25.0%USD 3.4 mn7.9%
Polyurethane and other polymers20.0%22.0%USD 2.8 mn8.5%

By fixation

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Sclera-sutured44.0%41.0%USD 6.2 mn6.7%
Sulcus-placed34.0%35.0%USD 4.8 mn7.8%
Capsular bag placement22.0%24.0%USD 3.1 mn8.4%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Eye hospitals52.0%51.0%USD 7.3 mn7.3%
Academic medical centres30.0%31.0%USD 4.2 mn7.8%
Ambulatory surgery centres18.0%18.0%USD 2.5 mn7.5%

Top 25 countries for aniridia implants by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 83.5% of 2026 revenue and the 25 countries below together hold 96.5%.

Exhibit 4United States is the largest country market at USD 5.9 mn in 2026, and the three largest countries hold 57.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Aniridia Implants market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 5.9 mn, 42.0%; Germany: USD 1.3 mn, 9.0%; United Kingdom: USD 0.84 mn, 6.0%; France: USD 0.70 mn, 5.0%; Japan: USD 0.70 mn, 5.0%; Canada: USD 0.56 mn, 4.0%; Italy: USD 0.49 mn, 3.5%; Spain: USD 0.42 mn, 3.0%; Australia: USD 0.42 mn, 3.0%; Brazil: USD 0.42 mn, 3.0%.United States5.9 mn 42.0%Germany1.3 mn 9.0%United Kingdom0.84 mn 6.0%France0.70 mn 5.0%Japan0.70 mn 5.0%Canada0.56 mn 4.0%Italy0.49 mn 3.5%Spain0.42 mn 3.0%Australia0.42 mn 3.0%Brazil0.42 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 5.9 mn42.0%USD 13 mn8.0%
2GermanyUSD 1.3 mn9.0%USD 2.4 mn6.5%
3United KingdomUSD 0.84 mn6.0%USD 1.6 mn7.0%
4FranceUSD 0.70 mn5.0%USD 1.4 mn7.1%
5JapanUSD 0.70 mn5.0%USD 1.4 mn7.1%
6CanadaUSD 0.56 mn4.0%USD 1.2 mn7.5%
7ItalyUSD 0.49 mn3.5%USD 0.95 mn6.9%
8SpainUSD 0.42 mn3.0%USD 0.84 mn7.1%
9AustraliaUSD 0.42 mn3.0%USD 0.87 mn7.5%
10BrazilUSD 0.42 mn3.0%USD 0.95 mn8.5%
11ChinaUSD 0.20 mn1.4%USD 0.51 mn9.7%
12NetherlandsUSD 0.17 mn1.2%USD 0.31 mn6.4%
13SwitzerlandUSD 0.15 mn1.1%USD 0.28 mn6.3%
14SwedenUSD 0.13 mn0.9%USD 0.25 mn6.4%
15BelgiumUSD 0.13 mn0.9%USD 0.25 mn6.4%
16IndiaUSD 0.13 mn0.9%USD 0.34 mn9.8%
17South KoreaUSD 0.13 mn0.9%USD 0.28 mn7.6%
18AustriaUSD 0.12 mn0.8%USD 0.22 mn6.4%
19TurkeyUSD 0.10 mn0.7%USD 0.23 mn8.6%
20MexicoUSD 0.10 mn0.7%USD 0.21 mn7.5%
21IsraelUSD 0.10 mn0.7%USD 0.21 mn7.5%
22RussiaUSD 0.10 mn0.7%USD 0.19 mn6.2%
23PolandUSD 84 thousand0.6%USD 0.17 mn7.5%
24DenmarkUSD 84 thousand0.6%USD 0.16 mn6.4%
25ArgentinaUSD 84 thousand0.6%USD 0.16 mn6.4%
Rest of worldUSD 0.49 mn3.5%USD 0.94 mn6.7%
Exhibit 5United States and Germany account for 53% of the USD 15 mn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Aniridia Implants market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 14 mn. United States: +USD 6.8 mn; Germany: +USD 1.1 mn; United Kingdom: +USD 0.81 mn; France: +USD 0.69 mn; Japan: +USD 0.69 mn; 20 other countries: +USD 4.4 mn; Rest of world: +USD 0.45 mn. Market value 2036: USD 29 mn.Market value 202614 mnUnited States+6.8 mnGermany+1.1 mnUnited Kingdom+0.81 mnFrance+0.69 mnJapan+0.69 mn20 other countries+4.4 mnRest of world+0.45 mnMarket value 203629 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • HumanOptics
  • Ophtec
  • Morcher

Group 2: Regional and specialist players

  • Alcon
  • Reper-NN
  • Rayner Surgical
  • Dr. Schmidt Intraocularlinsen

Group 3: Emerging and niche players

  • BrightMatter

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the aniridia implants market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.5% is calculated from the resulting values.

The market is divided by implant, by cause, by material, by fixation, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the aniridia implants market?

The global aniridia implants market is estimated at USD 13 mn in 2025 and USD 14 mn in 2026.

How fast will the aniridia implants market grow?

It is forecast to reach USD 29 mn by 2036, a compound annual growth rate of 7.5% from 2026, an increase of USD 15 mn.

Which country is the largest market for aniridia implants?

United States is the largest market by revenue at USD 5.9 mn in 2026, 42.0% of the global total. The three largest countries together hold 57.0%.

Which country is growing fastest?

Among the ten largest markets, Brazil is growing fastest at 8.5% a year from 2026 to 2036.

Which aniridia implants segment is largest?

In the by implant split, Custom artificial iris is the largest segment with 44.0% of 2026 revenue.

Who are the leading aniridia implants companies?

Global leaders include HumanOptics, Ophtec, Morcher.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Animal Wound Care Anti-Neoplastic Pharmaceutical Agents →

All Healthcare markets →

Request a sample